Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 45

1.

Resistance Is Futile: Targeting Mitochondrial Energetics and Metabolism to Overcome Drug Resistance in Cancer Treatment.

Bosc C, Selak MA, Sarry JE.

Cell Metab. 2017 Nov 7;26(5):705-707. doi: 10.1016/j.cmet.2017.10.013. Review.

2.

Eltrombopag modulates reactive oxygen species and decreases acute myeloid leukemia cell survival.

Kalota A, Selak MA, Garcia-Cid LA, Carroll M.

PLoS One. 2015 Apr 27;10(4):e0126691. doi: 10.1371/journal.pone.0126691. eCollection 2015.

3.

Mitochondrial energy metabolism and apoptosis regulation in glioblastoma.

Nagy A, Eder K, Selak MA, Kalman B.

Brain Res. 2015 Jan 21;1595:127-42. doi: 10.1016/j.brainres.2014.10.062. Epub 2014 Nov 4. Review.

PMID:
25451120
4.

Examination of physiological function and biochemical disorders in a rat model of prolonged asphyxia-induced cardiac arrest followed by cardio pulmonary bypass resuscitation.

Kim J, Yin T, Yin M, Zhang W, Shinozaki K, Selak MA, Pappan KL, Lampe JW, Becker LB.

PLoS One. 2014 Nov 10;9(11):e112012. doi: 10.1371/journal.pone.0112012. eCollection 2014.

5.

Mitochondrial dysfunction in peripheral blood mononuclear cells in pediatric septic shock.

Weiss SL, Selak MA, Tuluc F, Perales Villarroel J, Nadkarni VM, Deutschman CS, Becker LB.

Pediatr Crit Care Med. 2015 Jan;16(1):e4-e12. doi: 10.1097/PCC.0000000000000277.

6.

Mitochondrial DNA variant in COX1 subunit significantly alters energy metabolism of geographically divergent wild isolates in Caenorhabditis elegans.

Dingley SD, Polyak E, Ostrovsky J, Srinivasan S, Lee I, Rosenfeld AB, Tsukikawa M, Xiao R, Selak MA, Coon JJ, Hebert AS, Grimsrud PA, Kwon YJ, Pagliarini DJ, Gai X, Schurr TG, Hüttemann M, Nakamaru-Ogiso E, Falk MJ.

J Mol Biol. 2014 May 29;426(11):2199-216. doi: 10.1016/j.jmb.2014.02.009. Epub 2014 Feb 14.

7.

Distribution of oligodendrocyte loss and mitochondrial toxicity in the cuprizone-induced experimental demyelination model.

Acs P, Selak MA, Komoly S, Kalman B.

J Neuroimmunol. 2013 Sep 15;262(1-2):128-31. doi: 10.1016/j.jneuroim.2013.06.012. Epub 2013 Jul 26.

PMID:
23890807
8.

Increased platelet storage time is associated with mitochondrial dysfunction and impaired platelet function.

Perales Villarroel JP, Figueredo R, Guan Y, Tomaiuolo M, Karamercan MA, Welsh J, Selak MA, Becker LB, Sims C.

J Surg Res. 2013 Sep;184(1):422-9. doi: 10.1016/j.jss.2013.05.097. Epub 2013 Jun 19.

9.

Hemorrhagic shock and resuscitation are associated with peripheral blood mononuclear cell mitochondrial dysfunction and immunosuppression.

Villarroel JP, Guan Y, Werlin E, Selak MA, Becker LB, Sims CA.

J Trauma Acute Care Surg. 2013 Jul;75(1):24-31. doi: 10.1097/TA.0b013e3182988b1f.

10.

Mitochondrial energetic and AKT status mediate metabolic effects and apoptosis of metformin in human leukemic cells.

Scotland S, Saland E, Skuli N, de Toni F, Boutzen H, Micklow E, Sénégas I, Peyraud R, Peyriga L, Théodoro F, Dumon E, Martineau Y, Danet-Desnoyers G, Bono F, Rocher C, Levade T, Manenti S, Junot C, Portais JC, Alet N, Récher C, Selak MA, Carroll M, Sarry JE.

Leukemia. 2013 Nov;27(11):2129-38. doi: 10.1038/leu.2013.107. Epub 2013 Apr 9.

PMID:
23568147
11.

Manipulating thyroid status alters endoplasmic reticulum calcium homeostasis in rat cerebellum.

Cole JT, McMullen DC, Kean WS, Yarnell AM, Lucky JJ, Selak MA, Buonora JE, Grunberg NE, Verma A, Watson WD.

Indian J Exp Biol. 2012 Jan;50(1):7-18.

PMID:
22279935
12.

Reduced activity of AMP-activated protein kinase protects against genetic models of motor neuron disease.

Lim MA, Selak MA, Xiang Z, Krainc D, Neve RL, Kraemer BC, Watts JL, Kalb RG.

J Neurosci. 2012 Jan 18;32(3):1123-41. doi: 10.1523/JNEUROSCI.6554-10.2012.

13.

Blood cells from Friedreich ataxia patients harbor frataxin deficiency without a loss of mitochondrial function.

Selak MA, Lyver E, Micklow E, Deutsch EC, Onder O, Selamoglu N, Yager C, Knight S, Carroll M, Daldal F, Dancis A, Lynch DR, Sarry JE.

Mitochondrion. 2011 Mar;11(2):342-50. doi: 10.1016/j.mito.2010.12.003. Epub 2010 Dec 13.

14.

Neonatal exendin-4 leads to protection from reperfusion injury and reduced rates of oxidative phosphorylation in the adult rat heart.

Brown SB, Libonati JR, Selak MA, Shannon RP, Simmons RA.

Cardiovasc Drugs Ther. 2010 Jun;24(3):197-205. doi: 10.1007/s10557-010-6242-z.

15.

Mechanisms underlying metabolic and neural defects in zebrafish and human multiple acyl-CoA dehydrogenase deficiency (MADD).

Song Y, Selak MA, Watson CT, Coutts C, Scherer PC, Panzer JA, Gibbs S, Scott MO, Willer G, Gregg RG, Ali DW, Bennett MJ, Balice-Gordon RJ.

PLoS One. 2009 Dec 17;4(12):e8329. doi: 10.1371/journal.pone.0008329.

16.

Erythroid dysplasia, megaloblastic anemia, and impaired lymphopoiesis arising from mitochondrial dysfunction.

Chen ML, Logan TD, Hochberg ML, Shelat SG, Yu X, Wilding GE, Tan W, Kujoth GC, Prolla TA, Selak MA, Kundu M, Carroll M, Thompson JE.

Blood. 2009 Nov 5;114(19):4045-53. doi: 10.1182/blood-2008-08-169474. Epub 2009 Sep 4.

17.

Reactivating HIF prolyl hydroxylases under hypoxia results in metabolic catastrophe and cell death.

Tennant DA, Frezza C, MacKenzie ED, Nguyen QD, Zheng L, Selak MA, Roberts DL, Dive C, Watson DG, Aboagye EO, Gottlieb E.

Oncogene. 2009 Nov 12;28(45):4009-21. doi: 10.1038/onc.2009.250. Epub 2009 Aug 31.

PMID:
19718054
18.

Hypoxia-inducible factor 2 regulates hepatic lipid metabolism.

Rankin EB, Rha J, Selak MA, Unger TL, Keith B, Liu Q, Haase VH.

Mol Cell Biol. 2009 Aug;29(16):4527-38. doi: 10.1128/MCB.00200-09. Epub 2009 Jun 15.

19.

Ulk1 plays a critical role in the autophagic clearance of mitochondria and ribosomes during reticulocyte maturation.

Kundu M, Lindsten T, Yang CY, Wu J, Zhao F, Zhang J, Selak MA, Ney PA, Thompson CB.

Blood. 2008 Aug 15;112(4):1493-502. doi: 10.1182/blood-2008-02-137398. Epub 2008 Jun 6.

20.

Cell-permeating alpha-ketoglutarate derivatives alleviate pseudohypoxia in succinate dehydrogenase-deficient cells.

MacKenzie ED, Selak MA, Tennant DA, Payne LJ, Crosby S, Frederiksen CM, Watson DG, Gottlieb E.

Mol Cell Biol. 2007 May;27(9):3282-9. Epub 2007 Feb 26.

21.

Succinate dehydrogenase and fumarate hydratase: linking mitochondrial dysfunction and cancer.

King A, Selak MA, Gottlieb E.

Oncogene. 2006 Aug 7;25(34):4675-82. Review.

PMID:
16892081
22.

TIGAR, a p53-inducible regulator of glycolysis and apoptosis.

Bensaad K, Tsuruta A, Selak MA, Vidal MN, Nakano K, Bartrons R, Gottlieb E, Vousden KH.

Cell. 2006 Jul 14;126(1):107-20.

23.

Redox stress is not essential for the pseudo-hypoxic phenotype of succinate dehydrogenase deficient cells.

Selak MA, Durán RV, Gottlieb E.

Biochim Biophys Acta. 2006 May-Jun;1757(5-6):567-72. Epub 2006 May 17.

24.

Progressive accumulation of mitochondrial DNA mutations and decline in mitochondrial function lead to beta-cell failure.

Simmons RA, Suponitsky-Kroyter I, Selak MA.

J Biol Chem. 2005 Aug 5;280(31):28785-91. Epub 2005 Jun 9.

25.

Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase.

Selak MA, Armour SM, MacKenzie ED, Boulahbel H, Watson DG, Mansfield KD, Pan Y, Simon MC, Thompson CB, Gottlieb E.

Cancer Cell. 2005 Jan;7(1):77-85.

26.

Impaired oxidative phosphorylation in hepatic mitochondria in growth-retarded rats.

Peterside IE, Selak MA, Simmons RA.

Am J Physiol Endocrinol Metab. 2003 Dec;285(6):E1258-66.

27.

Impaired oxidative phosphorylation in skeletal muscle of intrauterine growth-retarded rats.

Selak MA, Storey BT, Peterside I, Simmons RA.

Am J Physiol Endocrinol Metab. 2003 Jul;285(1):E130-7. Epub 2003 Mar 11.

28.

Infantile leukoencephalopathy owing to mitochondrial enzyme dysfunction.

Kang PB, Hunter JV, Melvin JJ, Selak MA, Faerber EN, Kaye EM.

J Child Neurol. 2002 Jun;17(6):421-8.

PMID:
12174962
29.

Mitochondrial activity in Pompe's disease.

Selak MA, de Chadarevian JP, Melvin JJ, Grover WD, Salganicoff L, Kaye EM.

Pediatr Neurol. 2000 Jul;23(1):54-7.

PMID:
10963971
30.
31.

Neutrophil-platelet interactions in inflammation.

Selak MA.

Receptor. 1994 Spring;4(1):3-7. Review.

PMID:
8038704
32.
33.

Cytosolic calcium as a second messenger for collagen-induced platelet responses.

Smith JB, Selak MA, Dangelmaier C, Daniel JL.

Biochem J. 1992 Dec 15;288 ( Pt 3):925-9.

34.

Neutrophil elastase potentiates cathepsin G-induced platelet activation.

Selak MA.

Thromb Haemost. 1992 Nov 10;68(5):570-6.

PMID:
1333649
35.

Cyclic AMP does not inhibit collagen-induced platelet signal transduction.

Smith JB, Dangelmaier C, Selak MA, Ashby B, Daniel J.

Biochem J. 1992 May 1;283 ( Pt 3):889-92.

37.
38.

Cathepsin G binding to human platelets. Evidence for a specific receptor.

Selak MA, Smith JB.

Biochem J. 1990 Feb 15;266(1):55-62.

39.
40.

Cathepsin G is a strong platelet agonist released by neutrophils.

Selak MA, Chignard M, Smith JB.

Biochem J. 1988 Apr 1;251(1):293-9.

41.

Respiration capacity of mitochondria isolated from unfertilized and fertilized sea urchin eggs.

Selak MA, Scandella CJ.

Exp Cell Res. 1987 Apr;169(2):369-78.

PMID:
3556423
42.

Direct evidence for the existence of a neutrophil-derived platelet activator (neutrophilin).

Chignard M, Selak MA, Smith JB.

Proc Natl Acad Sci U S A. 1986 Nov;83(22):8609-13.

43.

Platelet activation induced by FMLP-stimulated neutrophils.

Selak MA, Chignard M, Smith JB.

Agents Actions Suppl. 1986;20:99-107. No abstract available.

PMID:
3101445
44.

Calcium compartmentation and regulation in myocytes.

Williamson JR, Thomas AP, Williams RJ, Alexander J, Selak MA.

Adv Exp Med Biol. 1986;194:573-90. Review. No abstract available.

PMID:
3092593
45.

Cytochrome changes in control and concanavalin A-stimulated lymphocytes.

Selak MA, Conover TE.

Arch Biochem Biophys. 1982 Jan;213(1):306-17. No abstract available.

PMID:
6277254

Supplemental Content

Loading ...
Support Center